Archive for 'Biopharmacy'
Detecting arthritis early on is one of the key challenges facing rheumatology. However, some patients present with undifferentiated arthritis, meaning that it is not possible to establish a diagnosis from the initial assessment. By analyzing our [...]
Delphi Genetics S.A., a Walloon SME located in Gosselies (Belgium) partners with US company Avaxia (Lexington, Massachusetts) to develop an improved biomolecules manufacturing and immunization process for Avaxia’s lead product candidate which is in clinical development [...]
ImmunXperts: launch of a unique fully integrated Immunogenicity service provider for biotherapeutics.
ImmunXperts s.a. a start-up located in Gosselies (Belgium) and specializing in the development of proprietary and innovative methods to assess the immunogenicity of novel biotherapeutics and biosimilars has raised USD 1 million in equity and bank [...]
Euroscreen, a Belgian drug discovery and development company providing first-in-class small molecule drug candidates for therapeutics areas such as hormonal disorders, inflammation and neurodegenerative diseases, announced an exclusive world-wide research collaboration and licensing agreement with Merck [...]
Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]
Belgo-American partnership between Promethera Biosciences and EMD Millipore to develop pre-clinical liver pharmaco-toxicological testing assay
The recent Belgo-American partnership between Promethera® Biosciences (Mont-Saint-Guibert, Belgium), and EMD Millipore (Billerica, MA USA) to develop an improved ready-to-use microfluidic perfusion liver assay, is BioWin’s latest ‘Success Story’. The initiative behind this strategic project [...]
Marie Curie research grant awards €3.8 million in funding to Bone Therapeutics (Gosselies, Belgium) and partners
As part of an expert pan-European consortium* BONE THERAPEUTICS has been awarded a share of the highly competitive Marie Curie grant1 in the amount of €3.8 million. The grant will fund a four-year project entitled BIO-INSPIRE [...]
Cardio3 BioSciences SA has announced that it has received €4.0 million of non-dilutive funding from the Walloon Region through the conclusion of a new recoverable cash advance (RCA) granted for an amount of €2.5 million and [...]